Invasive oxygen sensor for critically ill
| Reference number | |
| Coordinator | NEOSENSE TECHNOLOGIES AB |
| Funding from Vinnova | SEK 1 450 000 |
| Project duration | June 2014 - December 2016 |
| Status | Completed |
Important results from the project
The aim of the project was to achieve clear verification results with respect to the project´s clinical benefit, its market potential and technical functionality. During the project we have fulfilled these objectives, except fully reaching the target with respect to technical verification.
Expected long term effects
The technical verification has proceeded very well during the whole project, although some issues remain to be resolved. The effect of the interrupted funding from VFT2 means that we will continue to work on these issues with alternative funding. We estimate that within 1-3 months have solved problems that persist and are at that time ready to enter into a more formal product development.
Approach and implementation
We have largely made use of consultants in the verification project concerning issues regarding marketing, sales, and service. Even the preparation of the strategy for IPR and clinical evaluation have been carried out by consultants. The more advanced technical verification work we have conducted ourselves together with our catheters supplier.